Bpn14770    (DrugBank: BPN-14770)

1 disease
IDDisease name (Link within this page)Number of trials
206Fragile X syndrome1

206. Fragile X syndrome    [ 98 clinical trials,   73 drugs,   (DrugBank: 27 drugs),   46 drug target genes,   57 drug target pathways]
Searched query = "Fragile X syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 98 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03569631
(ClinicalTrials.gov)
July 9, 201825/5/2018A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X SyndromeA Randomized, Double-blind, Placebo-controlled, 2-period Crossover Study of BPN14770 in Adult Males With Fragile X SyndromeFragile X Syndrome;FXS;Fra(X) SyndromeDrug: BPN14770;Drug: PlaceboTetra Discovery PartnersNULLCompleted18 Years45 YearsMale30Phase 2United States